Literature DB >> 2644465

Nicotine vs placebo gum in general medical practice.

J R Hughes1, S W Gust, R M Keenan, J W Fenwick, M L Healey.   

Abstract

Three hundred fifteen smokers who attended a family practice clinic and wished to quit smoking were assigned in a random, double-blind manner to receive either nicotine (2 mg) or placebo gum. Smokers initially received brief advice from a physician and nurse, a slide presentation and written materials (29 to 35 minutes), and a single follow-up visit (12 to 20 minutes) one week after cessation. After corrections for marital status and income, 10% of those who received nicotine gum and 7% of those who received placebo gum reported continuous abstinence for 11 months and passed observer and biochemical verification (this difference was not statistically significant). We conclude that, when used in a nonselected group of smokers along with a brief intervention in a general medical practice, the pharmacologic effects of nicotine gum to increase cessation are either small or nonexistent.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2644465

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  22 in total

Review 1.  Do point prevalence and prolonged abstinence measures produce similar results in smoking cessation studies? A systematic review.

Authors:  John R Hughes; Matthew J Carpenter; Shelly Naud
Journal:  Nicotine Tob Res       Date:  2010-05-26       Impact factor: 4.244

2.  Role of nicotine dependence in smoking relapse: results from a prospective study using population-based recruitment methodology.

Authors:  J D Killen; S P Fortmann
Journal:  Int J Behav Med       Date:  1994

Review 3.  Future trends in the pharmacological treatment of smoking cessation.

Authors:  A H Glassman; L S Covey
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

Review 4.  Nicotine replacement therapy. What has been accomplished--can we do better?

Authors:  N L Benowitz
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

Review 5.  Is clonidine an effective smoking cessation therapy?

Authors:  S G Gourlay; N L Benowitz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

6.  Extended cognitive behavior therapy for cigarette smoking cessation.

Authors:  Joel D Killen; Stephen P Fortmann; Alan F Schatzberg; Christina Arredondo; Greer Murphy; Chris Hayward; Maria Celio; Deann Cromp; Dalea Fong; Maya Pandurangi
Journal:  Addiction       Date:  2008-08       Impact factor: 6.526

7.  Nicotine polacrilex dose effects: serum nicotine levels and sensory characteristics.

Authors:  S J Leischow; D P Sachs; M D Hansen; A G Bostrom
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

8.  How effective is nicotine replacement therapy in helping people to stop smoking?

Authors:  J L Tang; M Law; N Wald
Journal:  BMJ       Date:  1994-01-01

Review 9.  Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.

Authors:  Mark J Eisenberg; Kristian B Filion; Daniel Yavin; Patrick Bélisle; Salvatore Mottillo; Lawrence Joseph; André Gervais; Jennifer O'Loughlin; Gilles Paradis; Stephane Rinfret; Louise Pilote
Journal:  CMAJ       Date:  2008-07-15       Impact factor: 8.262

10.  Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis.

Authors:  Edward J Mills; Ping Wu; Dean Spurden; Jon O Ebbert; Kumanan Wilson
Journal:  Harm Reduct J       Date:  2009-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.